Riskpilot← Back to searchSign inGet full accessDrDropin Hud AB
ABActiveOrg 5592672165Kyrkogatan 19Medical specialists activities · NACE 8622Est. 20209 employees
Revenue 2024
SEK 26,3M
+50% vs 2023
EBITDA margin
-2.4%
-205% vs 2023
Equity ratio
23.0%
Financial strength
Net profit 2024
SEK -1,6M
-59% vs 2023
| Revenue | SEK 26,3M | +50% |
| EBITDA | SEK -620K | -205% |
| Net profit | SEK -1,6M | -59% |
| Total assets | SEK 7,2M | -17% |
| Equity | SEK 1,7M | +5674% |
| Employees | 9 | — |
Legal name
DrDropin Hud AB
Org number
5592672165
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
17 augusti 2020
Share capital
SEK 25 000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Fysisk läkarmottagning samt digital plattform för att bedriva hälsovård. Direkt eller indirekt, bedriva verksamhet inom utveckling av teknologi- och applikationer samt försäljning och licensiering av system inom ovanstående områden, samt annan därmed förenlig verksamhet.
Address
Kyrkogatan 19
Email
emma.gulbrandsen@drdropin.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 73 | 1 209 | 17 572 | 26 287 |
| Staff expenses | — | −543 | −4 013 | −5 394 |
| EBITDA | — | −2 125 | −203 | −620 |
| Depreciation & amort. | −0 | −42 | −766 | −948 |
| EBIT | 0 | −2 167 | −969 | −1 568 |
| Net financials | — | −1 | −17 | −2 |
| Profit before tax | 0 | −2 168 | −986 | −1 570 |
| Tax | −0 | — | — | — |
| Net profit | 0 | −2 168 | −986 | −1 570 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 74 | 4 316 | 8 620 | 7 196 |
| Equity | 25 | 25 | 29 | 1 658 |
| Long-term debt | 31 | 1 797 | 4 760 | 1 560 |
| Short-term debt | 18 | 2 494 | 3 831 | 3 978 |
| Total debt | 49 | 4 291 | 8 592 | 5 538 |
EBITDA margin
-2.4%
This company
15.8%
Market median
-115% vs market
20212024
Equity ratio
23.0%
This company
38.2%
Market median
-40% vs market
20212024
Return on equity
-94.7%
This company
18.4%
Market median
-615% vs market
20212024
Net profit margin
-6.0%
This company
8.1%
Market median
-174% vs market
20212024
Asset turnover
3.65×
This company
1.12×
Market median
+226% vs market
20212024
Debt / equity
3.34×
This company
0.62×
Market median
-439% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-08-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EA Chief Executive Officer | Chief Executive Officer | 2022 |
NS | Audit | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DrDropin Hud AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emma Anna-Kajsa Gulbrandsen | Chief Executive Officer | 0 companies |
| Nawras Shaker Hussein | Audit | 0 companies |
| Reza Sohrabi | Deputy Board Member | 0 companies |
| Ramtin Vedad | Chairman | 0 companies |